Chennai, August 07, 2014: TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a global business technology solutions provider with significant focus across two principal business areas, namely Life Sciences (LS) and Supply Chain Management (SCM) domains, today, announced the financial results for the first quarter of FY 2015. The Company has posted revenue of INR 1,615 million for this quarter, a 17.5% decline over the corresponding quarter of the previous year as the result of a strategic decision to divest in businesses that are not expected to add long term value to the Company.
Srinivasan H.R., Vice-Chairman and Managing Director, TAKE Solutions said, “In line with our strategy outlined at the start of FY 14, we are witnessing a positive impact on the growth of the Life Sciences business. This growth can be attributed to an improvement in the funding environment for biotechnology companies and an increased focus on enhancing drug development efficiency. Due to these changing dynamics, revenue from continuing business has registered a healthy growth and the margins have improved. However, the decline in revenue was due to a divestment in the Supply Chain business.” He further added, “We continue to streamline our businesses to improve profitability and increase our investment in understanding the best market opportunities and clients’ needs. This will enable us to achieve a strong position in the LS and SCM businesses.”
About TAKE Solutions
TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suite includes distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes. TAKE has been recognized as a ‘Leader’ in IDC Health Insights’ “IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment”. TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit www.takesolutions.com
contacts:
Annapoorna K., TAKE Solutions Ltd., This email address is being protected from spambots. You need JavaScript enabled to view it., Tel: +91 44 2435 7359/60
Murugan G, 20:20 MSL, This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile: +91 98412 78904
